SOX17 and laryngotracheoesophageal cleft: Moreover, node-positive LC patients displayed higher RASSF1A methylation levels than node-negative LC patients (p = 0.018, Figure 2(C3)), whereas higher SOX17 promoter methylation was observed in patients with systemic metastization (p = 0.029) (Figure 2(C4)).